| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |